HÄLSA Pharma GmbH
Active in EUDAMEDGermanyfrom SRN EUDAMED SRN DE-MF-000007407
- Devices
- 312
- Registrations
- EUDAMED
Catalogue
Refluthin Ref 302572391
Rifluduo Ref 307574308
Rifluduo Ref 307574391
Reloxan Ref 313571373
Refluthin Ref 1571302
Mar® plus 3% Nosový sprej Ref MD312
Rifluduo Ref 306574373
Dr. Storz Aloe Vera 97, 5 % Gel Ref 4500144
Naso Libero Ref 2006759
tetesept Nasen Heilsalbe Ref 44588
Refluthin Ref 302573308
Reloxan Ref 316571308
Reloxan Ref 316751302
Eucerin Actinic Control MD SPF 100 Ref 83585-00000-03
EspiForte Ref CATA-MD301-00000
DulcoSoft Ref 655302
Gelum®-Tropfen Ref 0067
Kochsalz 0.9% Inhalat N Pädia® 2.5 ml Ref 3002203
Bronchostop Kids Syrup Ref 9532061
Mastu® Salbe Ref 175554
Mastu® Zäpfchen Ref 175555
Reloxan Ref 313571391
Nasic® Hydro Care Ref 9908154
Rifluduo Ref 306573391
Eucerin Actinic Control MD SPF 100 Ref 83585-09900-03
Sicca-Gynaedron Ref FRT00202
Tussirex Night Ref 9532164
nasic salin duo Ref 9905454
Rifluduo Ref 319571373
tetesept Bronchosan Husten akut Lutschtabletten Ref 200001948
Reloxan Ref 305572308
Rifluduo Ref 306572373
Reloxan Ref 301573373
A.Vogel Oogdruppels droge ogen 10 ML Ref 9019310
Glandomed® Mundspüllösung Ref MD309
Reloxan Ref 305574373
Eucerin Actinic Control MD SPF 100 Ref 83585-07400-03
Lefax extra Ref 86987023
Refluthin Ref 573391
Neo Quitoso plus 100ml Ref 3000555
Coldamaris protect Augentropfen Ref 112015
Pump Dosing System 1ml Ref SCP162
Reloxan Ref 313571302
3558GB414200519 Ref 83585-00000-01
Reloxan Ref 301572373
Eucerin Actinic Control MD SPF 100 Ref 83585-06410-03
A.Vogel Oogdruppels Hooikoorts 10ml Ref 9019320
Reloxan Ref 308573391
Mar® plus 3% Nasenpflegespray Ref MD312
Showing 51-100 of 312
Company details
- EUDAMED SRN
- DE-MF-000007407
- SRN (system / procedure pack)
- DE-PR-000043992
- EUDAMED status
- Active
- EUDAMED registered name
- HÄLSA Pharma GmbH
- Registered address
- 5, Maria-Goeppert-Str., 23562, Luebeck, Germany
- [email protected]
- PRRC contact
- Karin Klose
EUDAMED certificates
6 certificates5 valid, 1 expiredMDR 6next expiry 13 Jul 2027
Notified body 0482 6 certificates
- 13980GB450260910 Issued
Technical documentation EU MDR
- Issued
- 10 Sep 2026
- Expires
- 9 Sep 2031
- 3558GB448260917 Supplemented
Quality management system EU MDR
- Issued
- 17 Sep 2026
- Expires
- 28 Jul 2031
- Reason
- Change approved
- 20527GB450260324 Supplemented
Technical documentation EU MDR
- Issued
- 24 Mar 2026
- Expires
- 29 Sep 2030
- Reason
- Add device or group
- 20416GB450260423 Supplemented
Technical documentation EU MDR
- Issued
- 23 Apr 2026
- Expires
- 26 Feb 2029
- Reason
- Change approved
- 20218GB450220714 Issued
Technical documentation EU MDR
- Issued
- 14 Jul 2022
- Expires
- 13 Jul 2027
- 3558GB448260420 Expired
Quality management system EU MDR
- Issued
- 20 Apr 2026
- Expires
- 28 Jul 2026
- Reason
- Add device or group
What HÄLSA Pharma GmbH makes
HÄLSA Pharma GmbH manufactures reusable device sterilization and disinfection containers, as well as a range of oral and nasal pharmaceutical formulations, including lozenges, nasal sprays, syrups, and capsules. Notable products include Simeticone Vegicaps® for digestive relief, Espumisan GOLD for infant colic, and nasal hygiene solutions like Just Nasendusche. The portfolio also covers respiratory treatments such as Tussirex Junior and Stryphnasal® N Nasenstifte, as well as otic preparations like Otodolor® direkt. Additional offerings include MD Marshmallow A for throat soothing and Dr. Böhm® optico for eye care.
The company’s products are classified under EU medical device regulations, including Class I, Class IIa, Class IIb, and Class III devices. All relevant products are registered in the EU’s eudamed database. The manufacturer is based in Germany.